Vimizim

Active Ingredient(s): Elosulfase Alfa
FDA Approved: * February 14, 2014
Pharm Company: * BIOMARIN PHARM

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Vimizim Overview

Morquio syndrome (referred to as mucopolysaccharidosis IV, MPS IV, Morquio-Brailsford syndrome, or Morquio)[1] is a rare metabolic disorder in which the body cannot process certain types of mucopolysaccharides (long chains of sugar molecules), which the body uses as lubricants and shock absorbers. This birth defect, which is autosomal recessive, is thus a lysosomal storage disorder that is usually inherited.[2]:544 In the US, the incidence rate for Morquio is...

Read more Vimizim Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Morquio_syndrome

Recent Vimizim Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Elosulfase Alfa
  • Injection: 5mg/5ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vimizim: (1 result)

Sorted by National Drug Code
  • 68135-100 Vimizim 5 mg/5ml Intravenous Injection, Solution, Concentrate by Biomarin Pharmaceutical Inc.

Other drugs which contain Elosulfase Alfa or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA